Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 40.14%-33.27M | ---- | -76.90%-55.58M | -1,401.06%-19.87M | 43.62%-31.42M | -105.86%-1.32M | -1,291.64%-55.73M | 348.41%22.59M | -91.83%4.68M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -75.13%-1.01M | ---- | 44.59%-579K | 21.36%-464K | 84.17%-1.05M | 71.92%-590K | -58.95%-6.6M | -988.60%-2.1M | -1,001.59%-4.15M |
| Attributable subsidiary (profit) loss | ---- | -27.83%4.99M | ---- | 4,841.43%6.92M | --3.95M | --140K | ---- | ---- | ---- | ---- |
| Impairment and provisions: | ---- | -31.90%6.63M | ---- | 32.90%9.73M | -175.47%-523K | -81.08%7.32M | 38.05%693K | 849.85%38.7M | 22.74%502K | 738.27%4.07M |
| -Impairment of property, plant and equipment (reversal) | ---- | --1.92M | ---- | ---- | ---- | -53.41%12.87M | ---- | 689.00%27.62M | ---- | --3.5M |
| -Impairmen of inventory (reversal) | ---- | 73.41%-92K | ---- | 94.59%-346K | ---- | -186.96%-6.39M | ---141K | 31,847.83%7.35M | ---- | -67.61%23K |
| -Impairment of trade receivables (reversal) | ---- | -1,201.08%-1.02M | ---- | -94.43%93K | ---- | -28.66%1.67M | ---- | --2.34M | ---- | ---- |
| -Other impairments and provisions | ---- | -41.71%5.82M | ---- | 1,311.65%9.98M | -162.71%-523K | -159.15%-824K | 66.14%834K | 152.81%1.39M | 22.74%502K | 32.77%551K |
| Revaluation surplus: | ---- | 323.63%6.47M | ---- | ---2.9M | ---2.53M | ---- | ---- | ---- | ---- | -198.34%-14.17M |
| -Other fair value changes | ---- | 323.63%6.47M | ---- | ---2.9M | ---2.53M | ---- | ---- | ---- | ---- | -198.34%-14.17M |
| Asset sale loss (gain): | ---- | -124.85%-1.07M | ---- | 1,217.97%4.29M | 1,644.88%4.37M | -100.79%-384K | -249.38%-283K | 49,346.94%48.46M | -247.27%-81K | -39.13%98K |
| -Loss (gain) from sale of subsidiary company | ---- | -125.21%-1.07M | ---- | 20,233.33%4.23M | --4.37M | ---21K | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -101.54%-1K | ---- | 117.91%65K | ---- | -100.75%-363K | -249.38%-283K | 49,346.94%48.46M | -247.27%-81K | -39.13%98K |
| Depreciation and amortization: | ---- | 37.59%17.54M | ---- | 145.99%12.75M | 593.17%6.7M | -94.45%5.18M | -98.15%967K | 0.95%93.35M | 20.47%52.15M | 18.75%92.47M |
| -Depreciation | ---- | 60.18%12.75M | ---- | 70.87%7.96M | 371.66%4.31M | -95.00%4.66M | -98.25%914K | 0.95%93.24M | 20.50%52.1M | 18.67%92.36M |
| -Amortization of intangible assets | ---- | 0.00%4.68M | ---- | 1,024.52%4.68M | --2.34M | --416K | ---- | ---- | ---- | ---- |
| Financial expense | ---- | 34.44%726K | ---- | 134.78%540K | 7.86%247K | -96.79%230K | -94.34%229K | -9.37%7.17M | 8.91%4.05M | 18.38%7.92M |
| Unrealized exchange loss (gain) | ---- | -534.78%-200K | ---- | 104.47%46K | -15.15%-821K | -172.65%-1.03M | -223.78%-713K | -61.26%1.42M | --576K | 522.32%3.65M |
| Special items | ---- | --3.83M | ---- | ---- | ---- | 21.78%-8.83M | -282.23%-10.05M | -111.07%-11.29M | 274.91%5.52M | -61.91%-5.35M |
| Adjustment items | ---- | ---- | ---- | ---- | ---- | ---- | ---10K | ---- | ---- | ---- |
| Operating profit before the change of operating capital | ---- | 118.71%4.64M | ---- | 16.93%-24.78M | 19.29%-8.94M | -125.84%-29.83M | -113.32%-11.08M | 29.43%115.47M | 332.89%83.2M | -33.72%89.22M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -84.19%92K | ---- | -90.56%582K | ---- | 209.33%6.17M | ---- | 187.15%1.99M | ---- | 20.99%-2.29M |
| Accounts receivable (increase)decrease | ---- | 12.19%8.78M | ---- | 187.36%7.83M | ---- | ---8.96M | ---- | ---- | ---3.62M | -29.98%-1.96M |
| Accounts payable increase (decrease) | ---- | -165.78%-19.58M | ---- | -177.89%-7.37M | ---- | 155.44%9.46M | ---- | -820.01%-17.06M | ---- | -116.07%-1.85M |
| Advance payment increase (decrease) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --40.09M | ---- |
| prepayments (increase)decrease | ---- | -260.31%-35.65M | ---- | 202.75%22.24M | -38.55%-23.04M | -2,310.02%-21.64M | ---16.63M | ---898K | ---- | ---- |
| Special items for working capital changes | ---- | 263.43%44.66M | ---- | 140.22%12.29M | 100.31%127K | 79.33%-30.55M | -970.38%-41.41M | -777.37%-147.79M | -124.53%-3.87M | 197.13%21.82M |
| Cash from business operations | ---- | -72.72%2.94M | ---- | 114.31%10.78M | 53.92%-31.85M | -56.08%-75.36M | -159.69%-69.12M | -146.01%-48.28M | 230.95%115.8M | -29.61%104.93M |
| Other taxs | ---- | -874.36%-1.14M | ---- | -11,800.00%-117K | ---73K | 100.03%1K | ---- | -25.21%-3.93M | -29.88%-3.93M | 71.12%-3.14M |
| Special items of business | -577.99%-25.51M | ---- | ---3.76M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from operations | -577.99%-25.51M | -83.11%1.8M | 88.22%-3.76M | 114.15%10.67M | 53.81%-31.93M | -44.32%-75.36M | -161.79%-69.12M | -151.30%-52.22M | 250.00%111.87M | -26.35%101.79M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -4.58%146K | 31.45%209K | 14.18%153K | -84.78%159K | -48.06%134K | -81.26%1.05M | -87.27%258K | 249.44%5.58M | 1,602.52%2.03M | 472.04%1.6M |
| Loan receivable (increase) decrease | ---- | ---- | ---- | 200.00%9M | --9M | ---9M | ---- | ---- | ---- | ---- |
| Decrease in deposits (increase) | --65K | 70.00%-15K | ---- | ---50K | ---- | ---- | ---- | 200.00%119.7M | ---52.3M | ---119.7M |
| Sale of fixed assets | ---- | 46.15%19K | ---- | -97.19%13K | ---- | -70.04%462K | ---- | 11,761.54%1.54M | ---- | -93.84%13K |
| Purchase of fixed assets | ---- | 72.64%-174K | 62.20%-96K | 94.78%-636K | 73.84%-254K | 64.84%-12.17M | 94.06%-971K | 26.78%-34.63M | -110.77%-16.35M | -12.78%-47.29M |
| Sale of subsidiaries | --303K | -132.36%-377K | ---- | --1.17M | ---- | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | 415.82%815K | -33.20%-7.79M | -94.95%158K | 52.63%-5.85M | 1,460.00%3.13M | ---12.35M | ---230K | ---- | ---- | ---- |
| Recovery of cash from investments | ---- | -99.76%1K | ---- | --420K | ---- | ---- | ---- | -99.57%610K | ---- | -68.05%142.42M |
| Cash on investment | ---4.97M | 94.38%-400K | ---- | 90.21%-7.11M | ---6.97M | -183.72%-72.63M | ---- | 74.71%-25.6M | 74.47%-21.7M | 77.89%-101.21M |
| Other items in the investment business | ---- | -69.51%5.39M | -100.01%-1K | 6.00%17.67M | 2,541.89%17.91M | 24.09%16.67M | 240.37%678K | 9,162.76%13.43M | -45.05%-483K | 31.82%145K |
| Net cash from investment operations | -1,800.93%-3.64M | -121.27%-3.14M | -99.07%214K | 116.79%14.77M | 8,760.75%22.95M | -209.11%-87.98M | 99.70%-265K | 165.02%80.64M | -173.12%-88.8M | -133.14%-124.02M |
| Net cash before financing | -721.48%-29.15M | -105.28%-1.34M | 60.46%-3.55M | 115.57%25.44M | 87.07%-8.97M | -674.71%-163.34M | -400.85%-69.39M | 227.82%28.42M | 4,270.52%23.06M | -126.16%-22.24M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 387.10%4.87M | --2.32M | --1M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Refund | ---- | ---- | ---- | ---1M | ---1M | ---- | ---- | ---- | ---- | ---- |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 352.55%225.71M |
| Interest paid - financing | 82.01%-43K | -34.44%-726K | 3.24%-239K | -134.78%-540K | -7.86%-247K | 96.79%-230K | 94.34%-229K | 9.37%-7.17M | -8.91%-4.05M | -18.38%-7.92M |
| Absorb investment income | 439.06%690K | --130K | --128K | ---- | ---- | --230K | --330K | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -923.40%-14.26M |
| Other items of the financing business | ---9.12M | ---44.51M | ---- | ---- | ---- | ---- | ---- | ---25.74M | ---25.87M | ---- |
| Net cash from financing operations | -505.17%-3.6M | -386.44%-56.22M | 114.26%889K | -590.79%-11.56M | -3,002.49%-6.24M | 97.52%-1.67M | 99.67%-201K | -145.31%-67.33M | -107.95%-60.47M | 374.50%148.62M |
| Effect of rate | ---21K | 325.71%596K | ---- | 8.53%140K | 214.81%566K | 114.18%129K | -191.64%-493K | 75.09%-910K | -42.64%538K | -717.23%-3.65M |
| Net Cash | -1,131.59%-32.75M | -514.64%-57.56M | 82.52%-2.66M | 108.41%13.88M | 78.14%-15.21M | -324.05%-165.01M | -86.04%-69.59M | -130.79%-38.91M | -26.24%-37.4M | 309.54%126.38M |
| Begining period cash | -52.29%52.02M | 14.77%108.98M | 14.82%109.03M | -63.45%94.96M | -63.45%94.96M | -13.29%259.84M | -13.29%259.84M | 69.36%299.67M | 69.36%299.67M | 20.76%176.94M |
| Cash at the end | -81.90%19.25M | -52.27%52.02M | 32.44%106.37M | 14.77%108.98M | -57.68%80.32M | -63.45%94.96M | -27.79%189.77M | -13.29%259.84M | 77.27%262.8M | 69.36%299.67M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.